Equity Overview
Price & Market Data
Price: $42.58
Daily Change: +$1.27 / 2.98%
Range: $40.88 - $42.72
Market Cap: $1,532,291,328
Volume: 46,636
Performance Metrics
1 Week: 5.75%
1 Month: 8.57%
3 Months: 45.31%
6 Months: 106.9%
1 Year: 209.9%
YTD: 137.1%
Company Details
Employees: 1000
Sector: Health technology
Industry: Medical specialties
Country: United States
Details
GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development. In addition, it develops minimal residual disease post-diagnostic tests. The company was incorporated in 2015 and is headquartered in Menlo Park, California.